During the COVID-19 pandemic, Young Indians (Yi), an initiative of the Confederation of Indian Industry (CII), featured ShivShivam Pharma Private Limited as an Emergency Medicine Supplier. The listing included essential COVID-19 medicines such as Tocilizumab, Remdesivir, and Favipiravir, supplied against valid medical prescriptions.
The feature recognized our efforts to ensure the timely availability of critical medicines during a period of unprecedented demand. Our team remained committed to supporting hospitals, healthcare professionals, and patients by maintaining a dependable supply chain and delivering medicines with speed and responsibility.
We prioritized product availability, regulatory compliance, and efficient coordination throughout the pandemic. These efforts enabled us to contribute to uninterrupted access to essential COVID-19 therapies when they were needed most.
Our presence on the Young Indians (Yi) – CII platform reflects the confidence placed in Shiv Shivam Pharma as a trusted pharmaceutical distribution partner during a national health emergency. It also reinforces our commitment to delivering reliable healthcare solutions, supporting the medical community, and ensuring access to specialty and life-saving medicines across India.
